Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.9094 | 75 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.83624 | 74 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.90322 | 75 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.87321 | 73 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.043 | 75 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.18403 | 78 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.89641 | 75 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.82563 | 74 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.84179 | 74 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.87446 | 74 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.88351 | 74 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.83818 | 74 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.14359 | 77 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.0436 | 76 |